Working... Menu

Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS) (HYDROPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02529475
Recruitment Status : Recruiting
First Posted : August 20, 2015
Last Update Posted : March 29, 2018
Information provided by (Responsible Party):
University Hospital, Grenoble

Brief Summary:
  • This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects
  • MR Perfusion Imaging will be assess in both cochlea as well
  • Primary auditory brain pathways will be evaluated through MR diffusion imaging

Condition or disease Intervention/treatment Phase
Meniere Disease Drug: Gadoteric acid Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
Actual Study Start Date : February 2016
Estimated Primary Completion Date : September 2018
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Gadoteric acid
Gadoteric acid 0.2 mmol/kg
Drug: Gadoteric acid
Comparison with patients with Meniere's disease

Primary Outcome Measures :
  1. Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted Imaging [ Time Frame: One MR scan (4 hours) ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years)
  • Informed consent signed
  • Medical examination performed prior to participation in research
  • Patients without history of inner ear disease
  • Recipient of a French social security scheme

Exclusion Criteria:

  • Patients minors
  • Patients on a legal protection regime type guardianship
  • Respiratory pathologies, cardiovascular, renal, diabetes
  • Claustrophobia
  • Contraindications to exposure to a magnetic field
  • Contraindications to injecting Dotarem ®

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02529475

Layout table for location contacts
Contact: Arnaud ATTYE, PH 0033 476 763 450

Layout table for location information
GrenobleUniversityHospital Recruiting
Grenoble, France, 38043
Contact: Arnaud ATTYE         
Sponsors and Collaborators
University Hospital, Grenoble
Layout table for investigator information
Principal Investigator: Arnaud ATTYE, PH University Hospital, Grenoble

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University Hospital, Grenoble Identifier: NCT02529475     History of Changes
Other Study ID Numbers: 38RC14.428
First Posted: August 20, 2015    Key Record Dates
Last Update Posted: March 29, 2018
Last Verified: March 2018

Additional relevant MeSH terms:
Layout table for MeSH terms
Meniere Disease
Endolymphatic Hydrops
Labyrinth Diseases
Ear Diseases
Otorhinolaryngologic Diseases